Mrs. Heather Renee Thomas, LMFTA Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 1035 Cheraw Street, Bennettsville, SC 29512 Phone: 843-454-0841 Fax: 843-454-0635 |
News Archive
Bbiotechnology company NEUROKIN, dedicated to the development of neuroprotective drugs to treat acute neurological diseases, announces today that the European Patent Office (EPO) has granted patent EP 1998778 protecting the use of NK-102, its most advanced drug candidate. This first European award constitutes an important milestone for NEUROKIN. An application for registration is under way in Brazil, Canada, China, USA and Japan.
The FinnGen study, launched in autumn 2017, is a broad academic-industrial collaboration between the Finnish biobanks and their respective Universities, University Hospitals, the Institute of Health and Welfare, the Finnish Red Cross Blood Service and now nine international pharmaceutical companies
For the third consecutive year, the Healthcare Financial Management Association (HFMA) performed a rigorous assessment of SIS Rules-Based Charging (RBC), an automated charge capture solution by Surgical Information Systems, and determined that it meets the stringent standards of the Peer Review program in the areas of effectiveness, quality and usability, price, value, and customer and technical support.
A minimally invasive treatment may target hunger at its source, another uses X-ray visible embolic beads to block arteries to the stomach and suppress hunger and a third explores the use of stem cells to repair vertebral disc degeneration. Initial results from all these studies were reported at the Society of Interventional Radiology's 37th Annual Scientific Meeting in San Francisco, Calif.
Micromet, Inc., a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases today announced that Bayer Schering Pharma AG has exercised its option under the option, collaboration and license agreement entered into on January 12, 2009 to develop a new BiTE antibody for the treatment of solid tumors.
› Verified 7 days ago